Information Provided By: 
Fly News Breaks for June 20, 2018
FMI, RHHBY, TSRO
Jun 20, 2018 | 10:10 EDT
Citi analyst Robyn Karnauskas said that investors have been asking about her M&A analysis for Tesaro, which she has published previously. Her analysis suggests the company could be valued at $140-$213 per share in a takeover scenario, noted Karnauskas, who maintains a Buy rating and $100 price target on Tesaro shares. The questions may have increased after Spanish website Intereconomia reported that following its acquisition of Foundation Medicine (FMI), Roche (RHHBY) is working with Citibank on a potential acquisition of Tesaro, The Fly notes.
News For TSRO;RHHBY;FMI From the Last 2 Days
RHHBY
Apr 26, 2024 | 11:59 EDT
RHHBY
Apr 25, 2024 | 11:44 EDT
RHHBY
Apr 24, 2024 | 06:33 EDT
RHHBY
Apr 24, 2024 | 06:30 EDT
